ShopSpell

Controversies in the Management of Gynecological Cancers [Paperback]

$96.99     $119.99   19% Off      (Free Shipping)
100 available
  • Category: Books (Medical)
  • ISBN-10:  1447171705
  • ISBN-10:  1447171705
  • ISBN-13:  9781447171706
  • ISBN-13:  9781447171706
  • Publisher:  Springer
  • Publisher:  Springer
  • Binding:  Paperback
  • Binding:  Paperback
  • Pub Date:  01-Apr-2016
  • Pub Date:  01-Apr-2016
  • SKU:  1447171705-11-SPRI
  • SKU:  1447171705-11-SPRI
  • Pages:  349
  • Pages:  349
  • Item ID: 103331440
  • List Price: $119.99
  • Seller: ShopSpell
  • Ships in: 5 business days
  • Transit time: Up to 5 business days
  • Delivery by: Oct 15 to Oct 17
  • Notes: Brand New Item. Not shipped to AK, HI, APO, FPO, AE.
This is a novel text that highlights the controversial areas in the management of gynecological cancers. None of the topics in this book have definitive answers; they represent the everyday decision-making facing gynecologists, oncologists, radiologists, pathologists and other health professionals treating women with these conditions. This book is not to be used as a traditional textbook; it is a text that specialists and trainees will use to help them weigh up the arguments that exist in a variety of areas in the treatment of gynecological cancers. Each chapter will have two or more authors, selected either for their opposing views or for their ability to provide an opposite view or opinion to the other. The content will be evidence-based, illustrating contrasting evidence and scientific opinion in the literature. Each chapter will close on a summary indicating the direction of research needed to address the issues being discussed.1. Controversies in the Treatment of Women with Early Stage Epithelial Ovarian Cancer.- 2. Recurrent Ovarian Cancer: When to Treat and How to Assess.- 3. New Views of Ovarian Carcinoma Types: How will this Change Practice?.- 4. Lymphadenectomy in Endometrial Cancer: The Controversy Rages Unabated.- 5. What is the Role of Adjuvant Radiotherapy and Chemotherapy in Endometrial Cancer?.- 6. Chemotherapy and/or Targeted Therapies for Advanced Endometrial Cancer: Time to Rethink?.- 7. Is Cervix Cancer a Disappearing Disease? Impact of HPV Vaccination in Developed Countries.- 8. What is the Role of Cytotoxic Chemotherapy in Advanced Cervical Cancer?.- 9. Response as a Measure of Treatment Efficacy in Clinical Trials:? Should RECIST Be Abandoned?.- 10. What are the Treatment Options for Recurrent Ovarian Cancer?.- 11. How To Study Rare Gynaecological Tumours: Trials or Registries?.- 12. What is the Best Treatment Model for Gynaecological Cancers? Does Centralization Help?.- 13. When Should Surgery be Performed for the First-Line Treatment of AdvalĂ%
Add Review